Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03028623 · ClinicalTrials.gov registry record · NA
Standard Tubal Ligation Versus Salpingectomy for Sterilization at the Time of Cesarean Delivery
A NA study of Method of Tubal Ligation at the Time of Cesarean Section, sponsored by University of Virginia.
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
- 1
- Study location
NCT03028623 is a NA study of Method of Tubal Ligation at the Time of Cesarean Section that has completed, run by University of Virginia. The registered enrollment target is 44 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03028623, a NA study of Method of Tubal Ligation at the Time of Cesarean Section, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to evaluate the feasibility and safety of salpingectomy versus standard tubal ligation in women undergoing surgical sterilization at the time of a planned cesarean delivery. Salpingectomy is currently being investigated as a potential strategy for ovarian cancer prevention. While this procedure is currently performed during hysterectomies, its feasibility at the time of cesarean delivery is not well established. This randomized, prospective clinical trial will compare the two sterilization methods to demonstrate that salpingectomy compared with standard tubal ligation at the time of cesarean delivery will not result in increased operative time, blood loss or other complications. This study is necessary to promote salpingectomy as a standard sterilization method during cesarean deliveries.
Conditions Studied
Interventions
- PROCEDURE Salpingectomy
- PROCEDURE Tubal ligation
Study Locations (1)
Virginia
- University of Virginia - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2017-05-01 |
| Est. Completion | 2018-03-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03028623
The ClinicalTrials.gov registry entry for NCT03028623 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Method of Tubal Ligation at the Time of Cesarean Section appearing as the primary indexed condition, and to 2 interventions - of which Salpingectomy is the first listed.
NCT03028623 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT03028623 about?
NCT03028623 is a clinical study titled "Standard Tubal Ligation Versus Salpingectomy for Sterilization at the Time of Cesarean Delivery". The objective of this study is to evaluate the feasibility and safety of salpingectomy versus standard tubal ligation in women undergoing surgical sterilization at the time of a planned cesarean delivery. Salpingectomy is currently being investigated as a potential strategy for ovarian cancer preven...
What is the current status of trial NCT03028623?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2017-05-01. Estimated completion is 2018-03-05.
What conditions does trial NCT03028623 study?
This clinical trial studies the following conditions: Method of Tubal Ligation at the Time of Cesarean Section.
What interventions are being tested in trial NCT03028623?
The interventions under investigation include: Salpingectomy (PROCEDURE), Tubal ligation (PROCEDURE).
Who is sponsoring clinical trial NCT03028623?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03028623 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.